Together, these data revealed that inhibition of ATGL targets metabolic and tumorigenic pathways in addition to multiple genes involved in diverse cellular functions that drive human colon cancer progression, especially when facilitated by high-fat-diet obesity. The gene discussed is PNPLA2; the disease is obesity due to melanocortin 4 receptor deficiency.